Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma.
D000284:Administration, Oral; D002114:Calcinosis / Q000097:blood / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D003882:Dermatomyositis / Q000150:complications*; D012968:Etidronic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010758:Phosphorus / Q000097:blood; D011859:Radiography; D012595:Scleroderma, Systemic / Q000150:complications*; D013997:Time Factors
D009943:Organophosphorus Compounds; D010758:Phosphorus; D012968:Etidronic Acid